Raymond James Maintains Outperform on Hologic, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Andrew Cooper maintains an 'Outperform' rating on Hologic (NASDAQ:HOLX), but has lowered the price target from $95 to $85.
October 18, 2023 | 11:52 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Raymond James maintains an 'Outperform' rating on Hologic, but lowers the price target from $95 to $85.
The news is directly related to Hologic. While the 'Outperform' rating is maintained, the lowering of the price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100